Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Suzan Willemsen"'
1
Functional and Hemodynamic Cardiac Determinants of Exercise Capacity in Patients With Systolic Heart Failure
Autor: Suzan Willemsen, Silvia Bugatti, Marco Metra, Johannes S. Sipkens, Dirk J. van Veldhuisen, Yoran M. Hummel, Jasper W. L. Hartog, Adriaan A. Voors, Kevin Damman
Publikováno v: American Journal of Cardiology, 110(9), 1336-1341. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
Decreased exercise capacity is the main symptom in patients with heart failure (HF). We assessed the association among noninvasively determined maximal cardiac output at exercise, systolic and diastolic cardiac functions at rest, and peak oxygen upta
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0282290b2e7bccd46fff3b45963fed24
https://doi.org/10.1016/j.amjcard.2012.06.039
Zobrazit plný text záznamu
2
Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome
Autor: Jasper W. L. Hartog, Dirk J. van Veldhuisen, M. Rebecca Heiner-Fokkema, Adriaan A. Voors, Suzan Willemsen
Publikováno v: Heart Failure Reviews
Heart failure reviews, 17(2), 221-228. SPRINGER
The prevalence of heart failure (HF) is increasing. A distinction is made between diastolic HF (preserved left ventricular ejection fraction (LVEF)) and systolic HF (reduced LVEF). Advanced glycation end-products (AGEs) are crystallized proteins that
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ac62450831ff10bfa23ce62fc98cbd
https://hdl.handle.net/11370/ef092931-c305-48bf-97fa-7dd068e91743
Zobrazit plný text záznamu
3
Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients
Autor: Yoran M. Hummel, Marieke H. I. van Ruijven, Suzan Willemsen, Jasper W. L. Hartog, Iwan C. C. van der Horst, Adriaan A. Voors, Dirk J. van Veldhuisen
Publikováno v: European Journal of Heart Failure, 13(1), 76-82. Wiley
Aims Advanced glycation end products (AGEs) are increased in patients with diabetes and are associated with diastolic dysfunction through the formation of collagen crosslinks in the heart. The association among AGEs, diastolic function, and aerobic c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0925a1988e533aac557464fd90e82ddf
https://hdl.handle.net/11370/d5755c6a-8c08-4517-ad10-12759fb712a4
Zobrazit plný text záznamu
4
Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure
Autor: Jan L. Posma, Suzan Willemsen, Dirk J. van Veldhuisen, Leen M. van Wijk, Yoran M. Hummel, Jasper W. L. Hartog, Adriaan A. Voors
Publikováno v: European Journal of Heart Failure, 12(3), 294-300. Wiley
Aims Previous small open label studies have shown that the advanced glycation end-product (AGE) breaker alagebrium may improve cardiac function in patients with chronic heart failure (HF). We report the design, methods and baseline characteristics of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936c02d6ed014761a1b8a4a648b61d2b
https://research.rug.nl/en/publications/c760d566-eb74-4d54-a7ce-fcb1931f31ce
Zobrazit plný text záznamu
5
The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction
Autor: Casper G. Schalkwijk, Tiny Jaarsma, Joline F. Roze, Jasper W. L. Hartog, Adriaan A. Voors, Suzan Willemsen, Iwan C. C. van der Horst, Dirk J. van Veldhuisen, Hans L. Hillege, Peter van der Meer
Publikováno v: American Heart Journal, 164(5), 742-U146. MOSBY-ELSEVIER
Introduction Advanced glycation end products (AGEs) are increased in patients with heart failure (HF). We studied the predictive value of plasma AGEs N-E-(carboxymethyl) lysine (CML), pentosidine, and the soluble form of its receptor (sRAGE) in a lar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f43399cb5b5c263179e7bdf3282b713
https://pubmed.ncbi.nlm.nih.gov/23137505
Zobrazit plný text záznamu
6
Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure
Autor: Yoran M. Hummel, Jan L. Posma, Suzan Willemsen, Jasper W. L. Hartog, Adriaan A. Voors, Hans L. Hillege, Dirk J. van Veldhuisen, Leen M. van Wijk
Publikováno v: European Journal of Heart Failure, 13(8), 899-908. Wiley
Aims Advanced glycation endproducts (AGEs) have been associated with the development and progression of chronic heart failure (CHF). Advanced glycation endproducts-crosslink breakers might be of benefit in HF, but only small-scale and uncontrolled da
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ab65df22931a5be76d25606ef027fd
https://pubmed.ncbi.nlm.nih.gov/21669961
Zobrazit plný text záznamu
7
Letter by Hartog et al Regarding Article, 'Advanced Glycation End Products Accumulate in Vascular Smooth Muscle and Modify Vascular but Not Ventricular Properties in Elderly Hypertensive Canines'
Autor: Suzan Willemsen, Jasper W. L. Hartog, Adriaan A. Voors
Publikováno v: Circulation, 119(10), E233-E233. LIPPINCOTT WILLIAMS & WILKINS
We thank Dr Hartog and colleagues for their interest in our study1 and agree with their conclusion that other advanced glycation end product (AGE) structures could be present in vascular (or ventricular) tissue. As acknowledged in the limitations sec
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864fe0da3f07ce655b24c03bf1bc889b
https://research.rug.nl/en/publications/935f0e71-9541-49fc-8615-d6f4de01a5df
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje